Literature DB >> 19152453

Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents.

Raquel Rocha1, Helma Pinchemel Cotrim, Almir Galvão Vieira Bitencourt, Daniel Batista Valente Barbosa, Admeia Souza Santos, Alessandro de Moura Almeida, Bruno Cunha, Isabel Guimarães.   

Abstract

AIM: To evaluate the prevalence and clinical characteristics of Nonalcoholic fatty liver disease (NAFLD) among asymptomatic Brazilian adolescents.
METHODS: Transversal observational study included asymptomatic adolescents with central obesity from private and public schools in Salvador-Bahia, northeastern Brazil. The children answered a questionnaire that included age, gender, race, and medical history, and were submitted to a complete physical exam and abdominal ultrasound. Biochemical exams included: ALT, AST, GGT, C reactive protein (CRP), fasting glucose, insulin, cholesterol and triglycerides. Criteria for NAFLD included: the presence of steatosis in ultrasound and/or high level of ALT, negative or occasional historic of intake of alcohol (<or= 140 g/wk), negative investigation for hepatitis A, B, C, auto-immune hepatitis, Wilson disease and hemochromatosis.
RESULTS: From October, 2005 to October, 2006, the study included 1801 subjects between 11 and 18 years of age and a mean age of 13.7+/-2.0 years. One hundred ninety-nine had central obesity. The prevalence of NAFLD was 2.3%, most of whom were male and white. Insulin resistance (IR) was observed in 22.9% of them and had positive correlations with ALT and GGT (P<0.05). Elevated CRP was observed in 6.9% of the cases; however, it was not associated with WC, IR or liver enzymes.
CONCLUSION: The prevalence of NAFLD in Brazilian adolescents was low. The ethnicity may have influence this frequency in the population studied, which had a large proportion of African descendents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152453      PMCID: PMC2653370          DOI: 10.3748/wjg.15.473

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?

Authors:  H P Cotrim; R Paraná; E Braga; L Lyra
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

2.  Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

Authors:  Saverio Stranges; Joan M Dorn; Paola Muti; Jo L Freudenheim; Eduardo Farinaro; Marcia Russell; Thomas H Nochajski; Maurizio Trevisan
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

3.  Association of nonalcoholic fatty liver disease with insulin resistance.

Authors:  G Marchesini; M Brizi; A M Morselli-Labate; G Bianchi; E Bugianesi; A J McCullough; G Forlani; N Melchionda
Journal:  Am J Med       Date:  1999-11       Impact factor: 4.965

4.  Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents.

Authors:  José R Fernández; David T Redden; Angelo Pietrobelli; David B Allison
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

5.  Steatohepatitis in obese children: a cause of chronic liver dysfunction.

Authors:  J R Moran; F K Ghishan; S A Halter; H L Greene
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

6.  Hepatic steatosis in obese Chinese children.

Authors:  D F Y Chan; A M Li; W C W Chu; M H M Chan; E M C Wong; E K H Liu; I H S Chan; J Yin; C W K Lam; T F Fok; E A S Nelson
Journal:  Int J Obes Relat Metab Disord       Date:  2004-10

7.  Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Reena Deutsch; Jeffrey B Rauch; Cynthia Behling; Robert Newbury; Joel E Lavine
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

8.  Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.

Authors:  Seyed-Moayed Alavian; Amir-Hooshang Mohammad-Alizadeh; Farzaneh Esna-Ashari; Gelayol Ardalan; Behzad Hajarizadeh
Journal:  Liver Int       Date:  2008-05-19       Impact factor: 5.828

Review 9.  Nonalcoholic fatty liver disease (NAFLD) in children.

Authors:  Pushpa Sathya; Steven Martin; Fernando Alvarez
Journal:  Curr Opin Pediatr       Date:  2002-10       Impact factor: 2.856

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  12 in total

1.  Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  Hüseyin Saadettin Uslusoy; Selim Giray Nak; Macit Gülten
Journal:  World J Hepatol       Date:  2011-08-27

2.  Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.

Authors:  Elizabeth L Yu; Shahrokh Golshan; Kathryn E Harlow; Jorge E Angeles; Janis Durelle; Nidhi P Goyal; Kimberly P Newton; Mary Catherine Sawh; Jonathan Hooker; Ethan Z Sy; Michael S Middleton; Claude B Sirlin; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2018-12-14       Impact factor: 4.406

3.  Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.

Authors:  Lucia Pacifico; Eleonora Poggiogalle; Vito Cantisani; Guendalina Menichini; Paolo Ricci; Flavia Ferraro; Claudio Chiesa
Journal:  World J Hepatol       Date:  2010-07-27

4.  Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).

Authors:  Christina M Parrinello; Bryan J Rudolph; Mariana Lazo; Linda C Gallo; Bharat Thyagarajan; Scott J Cotler; Qibin Qi; Tossaporn Seeherunvong; Denise C Vidot; Howard D Strickler; Robert C Kaplan; Carmen R Isasi
Journal:  J Clin Gastroenterol       Date:  2019-02       Impact factor: 3.062

Review 5.  Advancing the global public health agenda for NAFLD: a consensus statement.

Authors:  Jeffrey V Lazarus; Henry E Mark; Quentin M Anstee; Juan Pablo Arab; Rachel L Batterham; Laurent Castera; Helena Cortez-Pinto; Javier Crespo; Kenneth Cusi; M Ashworth Dirac; Sven Francque; Jacob George; Hannes Hagström; Terry T-K Huang; Mona H Ismail; Achim Kautz; Shiv Kumar Sarin; Rohit Loomba; Veronica Miller; Philip N Newsome; Michael Ninburg; Ponsiano Ocama; Vlad Ratziu; Mary Rinella; Diana Romero; Manuel Romero-Gómez; Jörn M Schattenberg; Emmanuel A Tsochatzis; Luca Valenti; Vincent Wai-Sun Wong; Yusuf Yilmaz; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-27       Impact factor: 46.802

6.  Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease.

Authors:  Roya Kelishadi; Parinaz Poursafa
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

7.  Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE.

Authors:  Josilda Ferreira Cruz; Mário Augusto Ferreira Cruz; José Machado Neto; Demetrius Silva de Santana; Cristiane Costa da Cunha Oliveira; Sônia Oliveira Lima
Journal:  Radiol Bras       Date:  2016 Jan-Feb

Review 8.  Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.

Authors:  I Moghaddasifar; K B Lankarani; M Moosazadeh; M Afshari; A Ghaemi; M Aliramezany; R Afsar Gharebagh; M Malary
Journal:  Int J Organ Transplant Med       Date:  2016-08-01

9.  Association of the Nonalcoholic Hepatic Steatosis and Its Degrees With the Values of Liver Enzymes and Homeostasis Model Assessment-Insulin Resistance Index.

Authors:  Mario Augusto Ferreira Cruz; Josilda Ferreira Cruz; Larissa Baracho Macena; Demetrius Silva de Santana; Cristiane Costa da Cunha Oliveira; Sonia Oliveira Lima; Alex Vianey Callado Franca
Journal:  Gastroenterology Res       Date:  2015-10-21

10.  Non alcoholic fatty liver disease in southern Iran: a population based study.

Authors:  Kamran Bagheri Lankarani; Fariborz Ghaffarpasand; Mojtaba Mahmoodi; Mehrzad Lotfi; Nima Zamiri; Sayed Taghi Heydari; Mohammad Kazem Fallahzadeh; Najmeh Maharlouei; Meisam Babaeinejad; Soheila Mehravar; Bita Geramizadeh
Journal:  Hepat Mon       Date:  2013-05-23       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.